GeoVax Labs Inc (GOVX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $928,290
Last updated: Nov 17, 2026 at 4:29 PM ET
GeoVax Labs Inc (GOVX) Statistics
GeoVax Labs (GOVX) has a market cap of $928,290. Its share count is up 838.45% from a year earlier. It holds $2.15M more cash than debt, 231.71% of its market cap.
Total Valuation
| Market Cap | $928,290 |
|---|---|
| Latest price (Nov 17, 2026) | $2.01 |
Key Dates
The next earnings report is expected on Apr 13, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Apr 13, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 99.26% over 52 weeks and trades 68.20% below its 50-day average.
| Beta (1Y) | 1.25 |
|---|---|
| 52-Week Change | -99.26% |
| 1-Month Change | -63.19% |
| 3-Month Change | -85.92% |
| 6-Month Change | -95.83% |
| 5-Year Change | -99.99% |
| 10-Year Change | -100.00% |
| Total Return (1Y) | -99.26% |
| Total Return (3Y CAGR) | -92.55% |
| Total Return (5Y CAGR) | -85.93% |
| Return vs SPY (1Y) | -110.74% |
| Max Drawdown (1Y) | -99.31% |
| Max Drawdown (3Y) | -99.97% |
| Sharpe Ratio (1Y) | -3.51 |
| Correlation with SPY (1Y) | 0.12 |
| 50-Day Average | $6.32 |
| 200-Day Average | $26.20 |
| 52-Week Range | $1.50 to $270.66 |
| RSI (14 Days) | 17.1 |
| Average Volume (20 Days) | 735.86K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.46x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.46x |
|---|---|
| Quick Ratio | 1.46x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -1591.45% and return on assets is -533.32% over the last 12 months.
| Return on Equity (ROE) | -1591.45% |
|---|---|
| Return on Assets (ROA) | -533.32% |
Scores
GOVX has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$18.33M |
| Pretax Income | -$18.26M |
| Net Income | -$18.26M |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 33.63% of the $3.42M in total assets.
| Cash and Equivalents | $2.15M |
|---|---|
| Total Debt | $0 |
| Net Cash | $2.15M |
| Net Cash Per Share | $5.47 |
| Working Capital | $978.60K |
| Shareholder Equity | $1.15M |
| Book Value Per Share | $2.92 |
| Total Assets | $3.42M |
| Total Liabilities | $2.28M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$16.50M |
|---|---|
| FCF Per Share | -$1.63 |
| Depreciation and Amortization | $50.92K |
Trailing 12 months through Sep 30, 2026.
Growth
Revenue grew 212.55% a year over 3 years.
| Revenue Growth (3Y CAGR) | +212.55% |
|---|---|
| Revenue Growth (5Y CAGR) | +6.42% |
Dividends and Yields
GOVX does not pay a dividend.
| Buyback Yield | -1473.10% |
|---|---|
| Shareholder Yield | -1473.10% |
Stock Splits
The last split was a 1-for-24 reverse split on Nov 11, 2026.
| Last Split Date | Nov 11, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:24 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About GOVX
What is GOVX's market cap?
GeoVax Labs has a market cap of $928,290.
How many shares of GOVX are outstanding?
GeoVax Labs has 393.55K shares outstanding. The count is up 838.45% from a year earlier.
Does GOVX pay a dividend?
No. GeoVax Labs does not pay a dividend.
How much debt does GOVX have?
GeoVax Labs has $0 of total debt and $2.15M of cash and equivalents, a net cash position of $2.15M.
GOVX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors